Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

["Membrane attack complex" formation in hemodialysis treatment].

A C Hauser1, K Derfler, F Stockenhuber

  • 1I. Medizinische Universitätsklinik, Wien.

Wiener Klinische Wochenschrift
|March 2, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[PIMS-a new pediatric challenge].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2021
Same author

Multicenter clinical experience of real life Dalbavancin use in gram-positive infections.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2019
Same author

Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2017
Same author

[Systemic lupus erythematosus : Unusual cutaneous manifestations].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2016
Same author

Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Infection·2016
Same author

Adverse events in apheresis: An update of the WAA registry data.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2016

Plasma concentrations of the membrane attack complex (MAC) increased significantly with Hemophan or Cuprophan dialysis membranes. Polysulfon membranes showed minimal MAC level changes, suggesting MAC as a biocompatibility marker.

Area of Science:

  • Nephrology
  • Biomedical Engineering
  • Immunology

Background:

  • Hemodialysis utilizes artificial membranes to filter blood.
  • Membrane biocompatibility is crucial for patient outcomes.
  • The membrane attack complex (MAC) is a key component of the complement system.

Purpose of the Study:

  • To investigate the plasma concentrations of the membrane attack complex (MAC) during hemodialysis.
  • To compare the impact of different dialysis membranes (Hemophan, Cuprophan, Polysulfon) on MAC levels.
  • To evaluate MAC as a potential biomarker for hemodialysis membrane biocompatibility.

Main Methods:

  • Plasma MAC levels were measured in 23 patients undergoing hemodialysis.
  • Patients were dialyzed using either Hemophan, Cuprophan, or Polysulfon membranes.

Related Experiment Videos

  • MAC concentrations were monitored throughout the dialysis sessions.

    • Main Results:

    • Hemophan and Cuprophan membranes led to a significant increase in plasma MAC levels (up to 250% of baseline).
    • A plateau in MAC levels was observed between 15 and 120 minutes for Hemophan and Cuprophan.
    • Polysulfon membranes resulted in only a slight increase in MAC concentrations.

    Conclusions:

    • Dialysis membrane material significantly influences MAC activation.
    • Hemophan and Cuprophan membranes elicit a stronger complement response compared to Polysulfon.
    • MAC may serve as a valuable marker for assessing the biocompatibility of hemodialysis membranes and understanding adverse effects.